北海道大学　大学院歯学研究院　口腔病態学分野

血管生物分子病理学教室

研究業績

国際学会発表

2023

  1. Hida K; Analysis of lung endotheliopathy in lethal mice infected with mouse-adapted SARS-CoV-2, Poster, 2023 KVBM Annual Meeting & AAVBM in partnership with ICoLA, Seoul, 2023.9.14-16, Seoul, Korea

2022

  1. Takeda R, Sawa H, Sasaki M, Orba Y, Maishi N, Ito W, Teshirogi T, Kitagawa Y, Hida Y, Hida K; Analysis of lung endotheliopathy in lethal mice infected with mouse-adapted SARS-CoV-2, Poster, 22nd International Vascular Biology Meeting (IVBM 2022), 2022.10.13-17, Oakland, CA, USA（2022 Travel Award受賞） 

2021

  1. Tsumita T, Maishi N, Matsuda A, Hida Y, Hida K: Tumor endothelial cells induce metastasis by neutrophil recruitment into tumor via LOX-1/Oxidized LDL axis, The 39th Sapporo International Cancer Symposium, 2021.7.6-7, Sapporo (Hybrid)
  2. Sato M, Maishi N, Hida Y, Matsuda A, Sakakibara-Konishi J, Konno S, Hida K: Angiogenic inhibitor administration prior to immunotherapy improves the therapeutic effects, The 39th Sapporo International Cancer Symposium, 2021.7.7, Sapporo (Hybrid)

2020

  1. Maishi N, Sakurai Y, Hatakeyama H, Li C, Alam MT, Kikuchi H, Morimoto H, Morimoto M, Akiyama K, Ohga N, Hida Y, Harashima H, Hida K: Novel Antiangiogenic Therapy Targeting Biglycan in Tumor Endothelial Cell Using Liposomal-siRNA Delivery System, E-poster, The 21st International Vascular Biology Meeting (IVBM 2020), 2020.9.9-12, Seoul, Korea
  2. Annan DA, Maishi N, Soga T, Dawood RIH, Li C, Kikuchi H, Hojo T, Morimoto M, Kitamura T, Alam MT, Minowa K, Shinohara N, Nam JM, Hida Y, Hida K: Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment E-poster, The 21st International Vascular Biology Meeting (IVBM 2020), 2020.9.19-12 Seoul, Korea
  3. Li C, Maishi N, Annan DA, Hida Y, Hida K: Biglycan deficiency normalizes tumor blood vessels and potentiates tumor immune responses, E-poster, The 21st International Vascular Biology Meeting (IVBM 2020), 2020.9.9-12, Seoul, Korea
  4. Tsumita T, Annan DA, Maishi N, Hida Y, Hida K: The role of LOX-1 in tumor endothelial cells on tumor metastasis, E-poster, The 21st International Vascular Biology Meeting (IVBM 2020), 2020.9.9-12, Seoul, Korea
  5. Kikuchi H, Nako Maishi, Dorcas A. Annan, Alam TM, Matsumoto R, Osawa T, Abe T, Hida Y, Harabayashi T, Ameda K, Kashiwagi A, Matsuno Y, Shinohara N, Hida K: Increased ABCB1 expression in tumor blood vessels of urothelial carcinoma after chemotherapy and chemoresistance, E-poster, The 21st International Vascular Biology Meeting (IVBM 2020), 2020.9.9-12, Seoul, Korea

2019

  1. Annan DA, Maishi N, Soga T, Dawood RIH, Li C, Kikuchi H, Hojo T, Morimoto M, Kitamura T, Alam MT, Minowa K, Shinohara N, Nam JM, Hida Y, Hida K,*：Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis, Meeting Global Health Challenges: 40 Years of Innovative Research at NMIMR, Accra, Ghana, 2019.11.29
  2. N., Kikuchi H., Abe T., Matsuno Y., Hida Y., Shinohara N., Hida K.：Increased ABCB1 expression in tumor blood vessels of urothelial carcinoma after chemotherapy, The 38th Sapporo International Cancer Symposium, 2019.7.12
  3. A.Annan, Maishi N., Soga T. R.Dawood, Li Cong, Kikuchi H., Hojo T., Morimoto M., Kitamura T., Mohammad T. Alam, Minowa K., Shinohara N., Hida Y., Hida K. : Carbonic anhydrase 2 (CAⅡ) is essential for tumor endothelial cell proliferation under various metabolic conditions, The 38th Sapporo International Cancer Symposium, 2019.7.12
  4. Morimoto M., Maishi N., Matsuda A. Kitamura T., Higashino F., Kitagawa Y., Hida Y., Hida K.：Promotion of metastasis via alteration of vascular endothelium by tumor exosome miRNA, Annual Meeting ISEV2019, 2019.4.26, Kyoto, Japan

2018

  1. Morimoto M., Maishi N., Matsuda A., Kitamura T., Higashino F., Yokoyama A., Kitagawa Y., Hida K.,：Promotion of metastasis via alteration of vascular endothelium by tumor exosome miRNA, The 66th Annual Meeting of Japanese Association for Dental Research, 2018.11.17, Sapporo, Japan
  2. Hida K., Kikuchi H., Maishi N., Abe T., Maruyama S., Harabayashi T., Ameda K., Matsuno Y., Hida Y., Shinohara N.：MDR1/ABCB1 upregulation in tumor blood vessels by chemotherapy-induced IL-8, 20th International Vascular Biology Meeting, 2018.6.3-7, Helsinki, Finland
  3. Hida Y., Morimoto H., Maishi N., Nishihara H., Hatanaka Y., Matsuno Y., Nakamura T., Hirano S., Hida K.：Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer, 20th International Vascular Biology Meeting, 2018.6.3-7, Helsinki, Finland
  4. D.A. Annan, N. Maishi N., Soga T., R. Dawood, Y. Hida Y., Hida K.：Tumor endothelial cells survive under lactic acidosis, AACR ANNUAL MEETING 2012, 2018.4.16, Chicago, Illinois
  5. Morimoto H., Maishi N., Hida Y., Nishihara H., Hatanaka Y., Matsuno Y., Nakamura Y., Hirano S., Hida K：Biglycan, tumor endothelial secreting proteoglycan, as possible biomarker for lung cancer, AACR ANNUAL MEETING 2012, 2018.4.16, Chicago, Illinois

2017

  1. Maishi N., Hida K.：Tumor endothelial cells in high metastatic tumors promote metastasis via biglycan, Protein Island Matsuyama 2017 International Symposium (PIM 2017), 2017.9.13 (Matsuyama, Japan)
  2. Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tsuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Matsuno Y., Shinohara N., Hida K.,：Analysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy, 2017 ASCO Annual Meeting, 2017. 6. 2-6, Chicago, Illinois

2016

  1. Hida K., Torii C., Maishi N., Morimoto M., Akiyama K., Kawamoto T., Minami T.,  Yoshioka Y., Mohammad Towfik Alam,  Shindoh M., Hida Y., Ochiya T：Tumor endothelial cells acquire drug resistance by exosomal-miR derived from high metastatic tumor, The 19th International Vascular Biology Meeting, 2016. 11.2, Boston, Massachusetts, USA
  2. Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Nagao-Kitamoto H., Mohammad Towfik Alam, Shindoh M., Hida Y. Hida K.：Tumor endothelial cells in high metastatic tumors promote metastasis via biglycan, The 19th International Vascular Biology Meeting, 2016. 11.2, Boston, Massachusetts, USA
  3. Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Demura T., Tsuda M., Tanaka S., Matsuno Y., Shinohara N., Hida K.：P-glycoprotein expression dynamics in tumor blood vessels of urothelial carcinoma during chemotherapy,” has been accepted for presentation at Vascular Biology, The 19th International Vascular Biology Meeting, 2016. 11.2, Boston, Massachusetts, USA
  4. Hida K., Maishi N., Ohga N., Hida Y.：Heterogeneity of Tumor endothelium, The 41th Naito Conference on “Cancer Heterogeneity and Plasticity: Relevance to Therapeutic Resistance”, 2016.7.7 (Sapporo, Japan)
  5. Hida K.：Heterogeneity of Tumor Endothelial Cells, Keystone Symposia on Molecular and Cellular Biology, 2016, 2016.4.1, Breckenridge, Colorado.
  6. Maishi N.：Tumor Endothelial Cells Promote Metastasis via Biglycan, Keystone Symposia on Molecular and Cellular Biology, 2016, 2016.3.30, Breckenridge, Colorado.
  7. Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Mohammad Towfik Alam, Shindoh M., Hida Y., Hida K：Tumor endothelial cells promote metastasis via biglycan secretion，Tenth AACR-JCA Joint Conference “Breakthroughs in Cancer Research: From Biology to Therapeutics”,2016.2.17 (Maui,Hawaii)

2015

  1. Hida K.：Tumor Endothelial Cells as Key Players in Tumor Metastasis，2015 Asian-Australian Vascular Biology Meeting (AAVBM)，10.15, Busan, Korea
  2. Hida K.：Tumor Endothelial Cells as Key Players in Tumor Metastasis，KAIST Vascular Biology Mini-Symposium 2015，2015.10.14, Daejeon, Korea
  3. Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Mohammad Towfik Alam, Shindoh M., Hida Y., Hida K：Tumor endothelial cells promote metastasis via biglycan secretion，The European Cancer Congress 2015, 2015.9.27 (Vienna, Austria)

2014

  1. Maishi N., Hida K.：“Characterization of tumor endothelial cells for development of new anti-angiogenic therapy”, The 17th HU-SNU JOINT SYMPOSIUM, 2014.11.28, Sapporo, Japan
  2. Maishi N., Hida K.：17th International Congress on Oral Pathology and Medicine, “Characterization of tumor endothelial cells for development of new anticancer drugs”, 2014.5.26 (Istanbul, Turkey)
  3. Hida K.：”Tumor endothelial cells as key players in tumor microenvironment.” International Symposium on Vascular Biology and Medicine, 2014.4.18（Sendai, Japan）
  4. Hida K.：”Heterogeneity of tumor endothelium”, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  5. Akiyama K., Ohga N., Hida Y., Maishi N., Alam Mohammad Towfik, Kawamoto T., Omura H., Yamada Y., Torii C., Shindoh M., Ohba Y., Hida K., P-gp inhibitor enhances antiangiogenic activity in metronomic chemotherapy, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  6. Maishi N., Ohba Y., Ohga N., Akiyama K., Hamada J., Yamamoto Y., Kawamoto T., Shindoh M., Hida Y., Hida K.: Tumor endothelial cells promote metastasis, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  7. Alam Mohammad Towfik, Nagao H., Ohga N., Akiyama K., Maishi N., Kawamoto T., Shinohara N., Taketomi A., Shindoh M., Hida Y., Hida K.: SBSN is a novel Tumor Endothelial Cell marker, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  8. Akino T., Nakayama H., Nonomura K., Hida K., Michael Klagsbrun : Netrin-1 promotes medulloblastoma cell invasiveness, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  9. Yamada K., Maishi N. Ohga N., Akiyama K., Kawamoto T., Alam Mohammad Towfik, Shindoh M. Takahashi N., Kamiyama T., Hida Y., Taketomi A., Hida K. : CXCL12/CXCR7 axis is important for tumor endothelial cell angiogenic property, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan
  10. Torii C., Ohga N., Akiyama K., Maishi N., Hojo T., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Hida Y., Shindoh M., Sato Y., Hida K.: Vasohibin-1 as a novel prognostic factor in oral squamous cell carcinoma, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japa
  11. Hojo T., Maishi N., Akiyama K., Ohga N., Kondoh M., Shindoh M., Fujisawa T., Hida Y., Hida K. : Proangiogenic phenotype of Tumor Endothelial Cells induced by ROS accumulation, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan

2012

  1. Hida K.：Finding Specific Anti-cancer Drugs Using Human Tumor Vascular Cells. 7th Annual International Partnering Conference “BIO-Europe Spring 201”, 2012.3.11-13, Barcelona, Spain
  2. Hida K., Omura H., Akiyama K., Ohga N.,Maishi N., Kawamoto T., Kondoh M., Hida Y.： Characterization of stem-like tumor endothelial cells, The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
  3. Ohga N.,Yamamoto K., Hida Y., Maishi N., Kawamoto T., Shindoh M., Hida K. : Biglycan is an autocrine angiogenic factor of tumor endothelial cells，The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
  4. Akiyama K., Ohga N., Hida Y., Maishi N., Alam Mohammad Towfik., Kawamoto T., Omura H., Yamada K., Torii C., Sakamoto H. Matsuda A., Hida K.:Tumor endothelium acquires drugresistance by MDR1/P-gp upregulationand metronomic chemotherapycombined with P-gp inhibitor enhancesantiangiogenic activity in vivo，The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
  5. Kondoh M., Ohga N., Akiyama K., Maishi N., Kawamoto T., Hida Y., Shindoh M., Hida K.: Hypoxia induces angiogenic factors andaneuploidy in micirovascular endothelialcells，The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
  6. Hida K.：“Heterogeneity of Tumor Endothelial Cells.” The 43rd International Symposium of The Princess Takamatsu Cancer Research Fund“Cancer Heterogeneity: Impact on Carcinogenesis, Cancer Stem Cell, Microenvironment, Diagnosis and Treatment” 2012.11.15（Tokyo, Japan）
  7. Hida K.：“Altered phenotype in endothelial cells in tumor microenvironment.”The 2nd International Symposium by JSPS Core-to-Core Program“Cooperative International Framework in TGF-β Family Signaling” 2012.10.30（Tokyo, Japan）
  8. Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Kaga K., Shinohara N., Shindoh M., Hirano S., Hida K. : Biglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells, the 17th International Vascular Biology Meeting, 2012.6.5, Wiesbaden, Germany
  9. Hida K., Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Maishi N., Akino T., Kondoh M., Shindoh M.: Tumor endothelial cell s acquire drug resistance by MDR1 upregulation, the 17th International Vascular Biology Meeting, 2012.6.4, Wiesbaden, Germany
  10. Kawamoto T., Ohga N., Akiyama K., Hirata N., Kitahara S., Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y., Hida K.: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, the 17th International Vascular Biology Meeting, 2012.6.4, Wiesbaden, Germany
  11. Maishi N., Ohba Y., Yamamoto K., Ohga N., Hamada J., Akiyama K., Kawamoto T., Osawa T., Kondoh M., Ohmura H., Shindoh M., Hida Y., Hida K. : Contribution of tumor endothelial cells to tumor metastasis, the 17th International Vascular Biology Meeting, 2012.6.2, Wiesbaden, Germany
  12. Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Kaga K., Hirano S., Shinohara N., Shindoh M., Hida K. : Biglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells, AACR ANNUAL MEETING 2012, 2012.4.4, Chicago, Illinois
  13. Osawa T., Ohga N., Hida Y., Kitayama K., Yamamoto Y., Kawamoto T., Maishi N., Kondoh M., Akiyama K., Onodera Y., Shinohara N., Nonomura K., Shindoh M., Hida K. : The role of lysyl oxidase on proangiogenic phenotypes of tumor endothelial cells, AACR ANNUAL MEETING 2012, 2012.4.3, Chicago, Illinois
  14. Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Ishikawa S., Maishi N., Tomoshige A., Kondoh M., Matsuda A., Inoue N., Shindoh M., Hida K. : Tumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois
  15. Kawamoto T., Ohga N., Akiyama K., Hirata N., Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y., Hida K.：Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois

2011

  1. Ohga N., Ishikawa S., Hida Y., Akiyama K., Kitayama K., Kondoh M., Maishi N., Kawamoto T., Ohsawa T., Yamamoto K., Shindoh M., Hida K.：Comparative characterization of tumor endothelial cells isolated from highly and low metastatic tumors, The 5th Meeting of Asian Society of Oral and Maxillofacial Pathology,“A New Insights into Tumor endothelial cell”, 2011.8.24（Fukuoka, Japan）(Invited Speaker)
  2. Maishi N., Ohga N., Hida Y., Ohba Y., Kawamoto T., Akiyama K., Kitayama K., Kondoh M., Ohsawa T., Yamamoto K., Inoue N., Shindoh M., Hida K.: Analysis of interaction between tumor endothelial cells and tumor cells, AACR 102nd ANNUAL MEETING 2011, 2011.4. 2-6, Orlando, Florida
  3. Kondoh M., Ohga N., Kitayama K., Akiyama K., Maishi N., Kawamoto T., Ohsawa T., Yamamoto K., Shindoh M., Inoue N., Hida Y., Hida K.: Gene expression analysis of circulating endothelial cells in cancer patients, AACR 102nd ANNUAL MEETING 2011, 2011.4. 2-6, Orlando, Florida

2010

  1. Hida K. : “Crosstalk between Tumor Endothelial Cells and Microenvironment.” The 13th Hokkaido University – Seoul National University Joint Sympojium, 26th Nov, 2010 (Sapporo)
  2. Hida K. Crosstalk between blood vessels and tumor　microenvironment. The Meeting of the 20th Anniversary Celebration of the Sister School Affiliation between Graduate School of Dental Medicine, Hokkaido University and School of Dentistry, Chonbuk National University：2010 Oct 14：Sapporo, Japan
  3. Hida K*. Akino T., Hida Y., Tsuchiya K., Freedman D., Muraki C., Ohga N., Matsuda K., Akiyama K., Kurosu T., Kondo M., Maishi N., Harabayashi T., Shinohara N., Nonomura K., Klagsbrun M. and Shindoh M.: Cytogenetic Abnormalities of Tumor Endothelial Cells in Human Malignant Tumors, AACR 101st ANNUAL MEETING 2010, 2010.4.17-21, Washington DC
  4. Hida Y., Ohga N., Muraki C., Akiyama K., Kondoh M., Maishi N., Kurosu T., Ishikawa S., Hirata N., Shindoh M. and Hida K*.: A Green Tea Polyphenol Epigallocatechin-3 Gallate Specifically Targets Tumor-Associated Endothelial Cells, AACR 101st ANNUAL MEETING 2010, 2010.4.17-21, Washington DC
  5. Akiyama K., Ohga N., Hida Y., Akino T., Hirata N., Kurosu T., Ishikawa S., Kondo M., Maishi N.,　Kawamoto T., Inoue N., Shindoh M. and Hida K*.: Endothelial cells acquire abnormalities by factors from tumor cells, AACR 101st ANNUAL MEETING 2010, 2010.4.17-21, Washington DC
  6. Ohga N., Hida K*.：Inhibitory Effects of Epigallocatechin-3 Gallate, a Polyphenol in Green Tea, on Tumor-Associated Endothelial Cells and Endothelial Progenitor Cells, AACR-JCA Joint conference: CANCER GENOMICS, EPIGENOMICS, AND THE DEVELOPMENT OF NOVEL THERAPEUTICS, 2010.2.5-9, Waikoloa,Hawaii, USA

2008年以前

  1. Totsuka Y., Kitamura T., Hida K., Higashino F. and Shindoh M.: Inorganic polyphosphate (poly-P) induces EGF-mediated cell proliferation by activating ERK phosphorylation. The 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine. 2008.10.9-11, Hersonissos, Crete, Greece
  2. Shindoh M., Tanaka S., Kitamura T., Hida K*., Higashino F. and Totsuka Y.: Pim-1 activates cell motility that induces malignant phenotypes of oral carcinoma. The 13th World Congress on Advances in Oncology and 11thInternational Symposium on Molecular Medicine. 2008/10/9-1 Hersonissos, Crete, Greece
  3. Hida K.：The 28th Sapporo International Cancer Symposium “TGF-β Signaling and Cancer”, 2008.6.26-27, Sapporo Japan.
  4. Hida K, Klagsbrun M, Hida Y and Shindoh M. “Chromosomal Abnormalities of Human Tumor-Associated Endothelial Cells” THE U.S.-JAPAN COOPERATIVE CANCER RESEARCH PROGRAM WORKSHOP （NCI-JSPS Joint Workshop）：2008 Mar 19-21：Kyoto Japan
  5. Shindoh M., Higashino F., Hida K*. and Kitamura T.: A novel mechanism of carcinogenesis. Symposiast Oral Cancer Seminar. 120thAnniversary between Thai and Japan Diplomatic Relations Program, 2007.11.29, Bangkok, Thailand
  6. Hida K*., Klagsbrun M., Hida Y. and Shindoh M.: Abnormality of tumor endothelial cells. International sessions 2 Cancer Angiogenesis.The 66th Annual Meeting of the Japanese Cancer Association, 2007.10.3-5（Yokohama, Japan）
  7. Tsuchiya K., Hida K*., Muraki C., Ohga N., Kondoh T., Miseki T., Shindoh M., Harabayashi T., Shonohara N., Nonomiya K. and Kobayashi M.: Adrenomedullin antagonist inhibits angiogenesis in renal cancer, 98thAnnual Meeting of AACR, 2007.4.13-17, Los Angels
  8. Muraki C., Hida K*., Hida Y., Tsuchiya K., Totsuka Y., Klagasburun M. and Shindoh M.: A cycloocygenase-2 inhibitor suppresses tumou-associated endothelial cell proliferation and migration, 98th Annual Meeting of AACR, 2007.4.13-17, Los Angels
  9. Hida K*., Hida Y., Klagsbrun M. and Shindoh M.: Abnormality of tumor-associated endothelial cells. AACR-JCA International Conference ”In the Forefront of Basic and Translational Cancer Research” 2007.1. 21-25,Waikoloa, Hawaii
  10. Hida K.: The COE 3rd International Symposium～Novel perspectives in cancer research and translation to the clinic“Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Antiangiogenic Therapies” 2006.11.9 (Sendai, Japan)
  11. Tsuchiya K., Hida K., Muraki C., Kondoh T., Miseki T., Shindoh M., Harabayashi T., Shinohara N., Nonomura K. and Kobayashi M.: Gene therapy trial for renal cancer in nude mice using an adrenomedullin antagonist, 97th Annual Meeting of AACR, 2006.4.1-5, Washington DC
  12. Muraki C., Hida K*., Hida Y., Shih SC., Tsuchiya K., Kobayashi M., Klagsbrun M. and Shindoh M.: The effect of cyclooxygenase-2 inhibition on tumor-associated endothelial cells. 97th Annual Meeting of AACR, 2006.4.1-5, Washington DC
  13. Hida K*.: AACR Special Conference in Cancer Research “Anti-Angiogenesis and Drug Delivery to tumors:Bench to Bedside and Back” Tumor-associated endothelial cells with cytogenetic abnormalities“ 2005.11.9-13 (Boston)
  14. Hida K*.: Boston Angiogenesis Meeting: BAM: “Tumor-associated endothelial cells with cytogenetic abnormalities” 2004.11.5 (Boston)
  15. Hida K*.: Gordon symposium：”Chromosome instability of Tumor associated Endothelial cells “2004. 8. 23, Andover, NH, USA
  16. Hida K*.: Harvard Medical School Surgical Research Spring Seminar ” Tumor Endothelial cells are not normal” 2003.4 (Boston)
  17. Hida K*.: Harvard Medical School Surgical Research Summer Retreat Seminar “Characterization of Tumor-deirived Endothelial cells” 2002.7 (Boston)